Retroviral gene therapy – where now?
- 31 July 2003
- journal article
- editorial
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 9 (7) , 277-278
- https://doi.org/10.1016/s1471-4914(03)00092-3
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Side effects of retroviral gene transfer into hematopoietic stem cellsBlood, 2003
- A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined ImmunodeficiencyNew England Journal of Medicine, 2003
- Correction of ADA-SCID by Stem Cell Gene Therapy Combined with Nonmyeloablative ConditioningScience, 2002
- Modelling the molecular circuitry of cancerNature Reviews Cancer, 2002
- Sustained Correction of X-Linked Severe Combined Immunodeficiency by ex Vivo Gene TherapyNew England Journal of Medicine, 2002
- Encapsulated cells producing retroviral vectors forin vivogene transferThe Journal of Gene Medicine, 2002
- Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 DiseaseScience, 2000
- T Lymphocyte-Directed Gene Therapy for ADA − SCID: Initial Trial Results After 4 YearsScience, 1995